Press Releases

Articles in this section

  • APN+ joins MTAAG+ in congratulating Malaysia on sofosbuvir compulsory license CL ends Gilead’s dangerous games with lives of HepC patients in Malaysia Result of hard fought efforts of community-based groups, NGOs and treatment providers

    20 September 2017, Bangkok and Kuala Lumpur: The Asia-Pacific Network of People living with HIV (APN+) joins the Positive Malaysian Treatment Access and Advocacy Group (MTAAG+) in welcoming the approval of a government use license (also known as compulsory license or CL) in Malaysia for (...) More

  • Gilead: Stop Blocking Access to Hepatitis C Treatment Thousands of activists urge company to change its policies on eve of shareholder meeting

  • AIDS 2014 : Activists Hold Die-In to Protest High Price of Gilead’s Hepatitis C Drug "HCV drugs are priced out of reach and out of control", Michel Sidibé, UNAIDS